Ardent Health Partners (NYSE:ARDT) Reaches New 1-Year Low After Analyst Downgrade

Ardent Health Partners, LLC (NYSE:ARDT)’s share price reached a new 52-week low during trading on Tuesday after Morgan Stanley lowered their price target on the stock from $23.50 to $22.00. Morgan Stanley currently has an overweight rating on the stock. Ardent Health Partners traded as low as $13.63 and last traded at $13.88, with a volume of 68275 shares. The stock had previously closed at $14.10.

Several other research firms also recently commented on ARDT. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $23.00 price objective on shares of Ardent Health Partners in a report on Thursday, November 14th. Leerink Partners lifted their price objective on Ardent Health Partners from $23.00 to $25.00 and gave the company an “outperform” rating in a research note on Tuesday, November 12th. Truist Financial lowered their target price on Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. KeyCorp started coverage on Ardent Health Partners in a report on Friday, October 11th. They issued an “overweight” rating and a $24.00 price target for the company. Finally, JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $20.00 price objective on shares of Ardent Health Partners in a research note on Tuesday, December 17th. Two analysts have rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, Ardent Health Partners presently has a consensus rating of “Buy” and an average price target of $21.55.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the stock. R Squared Ltd acquired a new stake in Ardent Health Partners during the 4th quarter worth $37,000. BNP Paribas Financial Markets acquired a new position in Ardent Health Partners during the third quarter worth about $42,000. Financial Management Professionals Inc. purchased a new stake in Ardent Health Partners during the 3rd quarter valued at about $50,000. MetLife Investment Management LLC acquired a new stake in Ardent Health Partners in the 3rd quarter valued at about $135,000. Finally, JPMorgan Chase & Co. purchased a new position in Ardent Health Partners in the 3rd quarter worth approximately $154,000.

Ardent Health Partners Trading Up 2.0 %

The company has a quick ratio of 1.78, a current ratio of 1.91 and a debt-to-equity ratio of 0.78. The company has a fifty day moving average of $16.11.

Ardent Health Partners (NYSE:ARDT) last released its quarterly earnings data on Wednesday, November 6th. The company reported $0.19 earnings per share for the quarter, missing analysts’ consensus estimates of $0.29 by ($0.10). The business had revenue of $1.45 billion during the quarter, compared to the consensus estimate of $1.46 billion. Research analysts predict that Ardent Health Partners, LLC will post 1.22 earnings per share for the current year.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.